NCT02141282 · Interventional trial
A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor Therapy
Overall registry status Completed
Phase 2
Conditions Chronic Lymphocytic Leukemia
Delaware Valley sites
- University of Pennsylvania /ID# 126860 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory